Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
This study has been completed.
Study NCT00409773 Information provided by Merck
First Received on December 8, 2006. Last Updated on April 10, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypercholesterolemia
Metabolic Syndrome
Additional conditions recognized in this trial
Coronary Disease
Metabolic Syndrome X
More general conditions related to this trial
Cardiovascular Diseases
Dyslipidemias
Glucose Metabolism Disorders
Heart Diseases
Hyperinsulinism
Hyperlipidemias
Insulin Resistance
Lipid Metabolism Disorders
Metabolic Diseases
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
ezetimibe (+) simvastatin
Comparator: atorvastatin calcium
Comparator: Placebo (unspecified)
Additional drug interventions recognized in this trial
Atorvastatin
Ezetimibe
Simvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Merck
Back to top of Main Content
